Clinical Trials Sponsored by ReGen Theranostics, Inc.

Total 75 results

Timothy J Nelson, MD, PhD
Mayo Clinic

Completed

Phase I Safety and Feasibility Study of Intracoronary Delivery of Autologous Bone Marrow Derived Mononuclear Cells

Congenital Heart Disease

United States
Da Zen Theranostics Inc

Recruiting

A Pharmacokinetic and Pharmacodynamic Study of DZ-002 in Patients With Advanced Solid Malignancies or Lymphoma

Lymphoma | Solid Tumor

United States
EGEN, Inc.

Terminated

A Study of the Safety and Biological Activity of Intraperitoneal (IP) EGEN-001 Administered Alone and in Combination With Standard Chemotherapy in Colorectal Peritoneal Carcinomatosis Patients

Colorectal Cancer

United States
EGEN, Inc.

Completed

Safety and Efficacy of EGEN-001 Combined With Carboplatin and Docetaxel in Recurrent, Platinum-Sensitive, Ovarian Cancer

Ovarian Neoplasms

United States
EGEN, Inc.

Terminated

Safety Study of phIL-12-005/PPC to Treat Recurrent Ovarian Cancer

Ovarian Neoplasms

United States
Timothy J Nelson, MD, PhD
Mayo Clinic; Children's Hospital of Philadelphia; University of Oklahoma

Completed

A Prospective Study of Patients With Hypoplastic Left Heart Syndrome (HLHS) Following Stage II Surgical Palliation

Hypoplastic Left Heart Syndrome

United States
American Regent, Inc.

Not yet recruiting

Tralement Versus a Fixed-dose Trace Element Combination Product of Zinc, Copper, and Selenious Acid to Evaluate Product Safety in Pediatric Patients >3 to 17 Years of Age Requiring Long-term Parenteral Nutrition

Manganese Safety in Pediatric Patients
Reven Pharmaceuticals, Inc.

Active, not recruiting

Tolerability and Efficacy of RJX in Patients With COVID-19 (RJX)

COVID-19 | Acute Respiratory Distress Syndrome | SARS-CoV-2 | Hypoxemia

United States
American Regent, Inc.

Completed

Placebo-Controlled Study to Investigate the Efficacy & Safety of Injectafer in the Treatment of RLS

Restless Legs Syndrome (RLS)

United States
American Regent, Inc.

Completed

Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia

Anemia

United States
American Regent, Inc.

Completed

Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients

Postpartum Anemia

United States
American Regent, Inc.

Completed

VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease

Anemia

United States
American Regent, Inc.

Completed

Safety and Tolerability of a Single Dose of FCM vs. Standard of Care in Treating Iron Deficiency Anemia

Anemia

United States
American Regent, Inc.

Completed

Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Standard of Care in Treating Iron Deficiency Anemia

Anemia

United States
American Regent, Inc.

Completed

Hypophosphatemia With Ferric Carboxymaltose Vs. Iron Dextran in Iron Deficiency Secondary to Heavy Uterine Bleeding

Iron Deficiency Anemia
American Regent, Inc.

Completed

Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer

Non-Small Cell Lung Cancer

United States
American Regent, Inc.

Completed

Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis

Anemia
American Regent, Inc.

Completed

Pharmacokinetic Study of Intravenous Iron Sucrose in Adolescents on Hemodialysis or Peritoneal Dialysis Receiving Epoetin

Anemia
American Regent, Inc.

Completed

Taxoprexin Treatment for Advanced Skin Melanoma

Metastatic Melanoma
American Regent, Inc.

Unknown

Trial to Evaluate the Utility of Serum Hepcidin Levels to Predict Response to Oral or IV Iron and to Compare Safety, Effect on Quality of Life, and Resource Utilization of Injectafer vs Intravenous Standard of Care for the Treatment of IDA in an Infusion Center Setting

Iron Deficiency Anemia (IDA)
American Regent, Inc.

Terminated

Randomized Double Blind Placebo Controlled Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopath

Calciphylaxis | Calcific Uremic Arteriolopathy

United States
American Regent, Inc.

Completed

Study of the Safety, Tolerability and Analgesic Efficacy of Multiple Doses of Ketorolac Tromethamine (IN) for Postoperative Pain

Postoperative Pain

New Zealand
CK Regeon Inc.

Completed

Safety, Tolerability, and Pharmacokinetic Evaluations of CKR-051 After Transdermal Administration in Healthy Male Subjects

Healthy

Korea, Republic of
American Regent, Inc.

Completed

Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Unsatisfactory Response Oral Iron Under Study Protocol 1VIT17044

Iron Deficiency Anemia

United States
American Regent, Inc.

Completed

Safety and Efficacy of Iron Sucrose in Children

Anemia | Chronic Kidney Disease

United States
Reven Pharmaceuticals, Inc.

Unknown

Revascularization of Stenosed Vessels Using Optimized Treatment of Rejuveinix for Reversing Endothelial Dysfunction (RESTORE)

Peripheral Arterial Disease | Critical Limb Ischemia
American Regent, Inc.

Completed

Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)

Iron Deficiency Anemia

United States
American Regent, Inc.

Completed

Intravenous (IV) Iron vs. No Iron as the Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy

Anemia
American Regent, Inc.

Completed

Intravenous (IV) Iron Preparation (VIT-45) in the Treatment of Restless Legs Syndrome (RLS)

Restless Legs Syndrome (RLS)
American Regent, Inc.

Completed

Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients

Anemia

United States
American Regent, Inc.

Completed

Iron Sucrose In The Treatment of Restless Legs Syndrome: Safety of Three Dose Regimens as Evaluated by Clinical Assessments

Restless Legs Syndrome
American Regent, Inc.

Completed

Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in Subjects Who Display Postpartum Anemia

Anemia

United States
American Regent, Inc.

Withdrawn

Safety Assessment of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumoxytol (Feraheme) or Iron Dextran (INFed or Dexferrum) (ASSURED)

Iron Deficiency Anemia

United States
American Regent, Inc.

Completed

Taxoprexin® Treatment for Advanced Eye Melanoma

Metastatic Melanoma

United States
American Regent, Inc.

Completed

Pharmacokinetics, Safety, and Efficacy of SPRIX in 12 to 17 Year Old Patients vs. Adult Patients Undergoing Open Surgical Procedures

Pain

United States
American Regent, Inc.

Completed

Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia

Anemia

United States
American Regent, Inc.

Not yet recruiting

Tralement Versus a Fixed-dose Trace Element Combination Product of Zinc, Copper, and Selenious Acid to Evaluate Product Safety in Adult Patients Requiring Long-term Parenteral Nutrition

Manganese Safety in Adults
American Regent, Inc.

Withdrawn

Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency Anemia

Iron Deficiency, Anaemia

United States
American Regent, Inc.

Terminated

Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia

Restless Legs Syndrome (RLS)

United States
American Regent, Inc.

Completed

A Study to Characterize the PK and PD Profile of IV FCM in Pediatric Subjects 1-17 Years Old With IDA

Iron Deficiency Anemia (IDA)

Poland, Russian Federation
American Regent, Inc.

Completed

Multicenter Randomized Active-controlled Study to Investigate Efficacy & Safety of IV FCM in Pediatric Patients With IDA

Iron Deficiency Anemia

United States
American Regent, Inc.

Completed

Efficacy and Safety of Venofer (Iron Sucrose Injection USP) in Patients Receiving Peritoneal Dialysis

Anemia
American Regent, Inc.

Completed

Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injectafer® (IRON CLAD)

Cancer and Chemotherapy Related Anemia

United States
American Regent, Inc.

Completed

Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia (IDA) Secondary to Inflammatory Bowel Disease (IBD) or Gastric Bypass

Iron Deficiency Anemia Secondary to IBD or Gastric Bypass
American Regent, Inc.

Completed

Registry to Evaluate Maintenance Treatment With Venofer in Pediatric Patients With Chronic Kidney Disease

Chronic Kidney Disease

United States
American Regent, Inc.

Completed

Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease Patients

Anemia

United States
American Regent, Inc.

Completed

Long Term Safety Study of (VIT45) Extension Study: Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease

Anemia

United States
American Regent, Inc.

Completed

Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding

Anemia

United States
American Regent, Inc.

Completed

Blinded Randomized Placebo-Controlled Study Efficacy and Safety of Injectafer in ID Patients With Fibromyalgia

Fibromyalgia | Iron Deficiency

United States
American Regent, Inc.

Completed

Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal Function (REPAIR-IDA)

Iron Deficiency Anemia | Impaired Renal Function

United States

3

Subscribe